BioPharma Credit PLC's Fiscal Year is From January To December.
The item "Price-To-Cashflow-Ratio" stands at 10.08 as of 06/30/2025, the highest value at least since 03/31/2024, the period currently displayed.
As of the end of BioPharma Credit PLC's second quarter, the item "Price To Cashflow Ratio" stands at 10.08. This represents an increase of 16.92 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 157.02 percent compared to the value the year prior.
The 1 year change in percent is 157.02.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Price To Cashflow Ratio | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Price To Cashflow Ratio | 186,696,990,720.00 |
![]() | BlackRock Inc - Price To Cashflow Ratio | 166,346,604,544.00 |
![]() | KKR & Co LP - Price To Cashflow Ratio | 119,832,821,760.00 |
![]() | Mitsubishi Corp. - Price To Cashflow Ratio | 89,722,540,958.42 |